Improving the Drug Development Process
- 22 January 2014
- journal article
- viewpoint
- Published by American Medical Association (AMA) in JAMA
- Vol. 311 (4), 355-356
- https://doi.org/10.1001/jama.2013.283742
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Evaluation of Excess Significance Bias in Animal Studies of Neurological DiseasesPLoS Biology, 2013
- A call for transparent reporting to optimize the predictive value of preclinical researchNature, 2012
- Faculty Opinions recommendation of Believe it or not: how much can we rely on published data on potential drug targets?Published by H1 Connect ,2011
- How to improve R&D productivity: the pharmaceutical industry's grand challengeNature Reviews Drug Discovery, 2010
- Risks and Benefits of Phase 1 Oncology Trials, 1991 through 2002New England Journal of Medicine, 2005